Trials / Completed
CompletedNCT00785083
A Study of the Effect of FTY720 on Pulmonary Function in Patients With Moderate Asthma
A Double-blind, Randomized, Placebo-controlled, Parallel, Time-lagged, Ascending, Multi-centre, Multiple-dose Study to Measure the Magnitude and Time Course of the Effect of FTY720 on FEV1 and Other Pulmonary Function Tests (FVC, FEF25-75%, and FEV1/FVC) in Patients With Moderate Asthma
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- Novartis · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate the effect of FTY720 on the lung function of patients with moderate asthma
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | FTY720 | |
| DRUG | Placebo |
Timeline
- Start date
- 2008-09-01
- Primary completion
- 2009-02-01
- First posted
- 2008-11-05
- Last updated
- 2016-11-18
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT00785083. Inclusion in this directory is not an endorsement.